Jeantet advises Turenne Santé in connection with its acquisition of a minority stake in H.A.C.Pharma to support the company’s development and strengthen its product portfolio

 

Paris, February 2, 2022– Jeantet advised Turenne Santé in connection with its acquisition of a minority stake in the pharmaceutical company H.A.C. Pharma, via the FPCI (Fonds Professionnel de Capital Investissement, or Professional private equity investment fund) Capital Santé 2, as lead investor, and BNP Paribas Développement. This transaction marks a new stage in the company’s development, as it seeks to continue launching new drugs and accelerate the expansion of its product portfolio.

With over €280 million under management, including more than €185 million for the FPCI Capital Santé 2, Turenne Santé supports healthcare companies in their development and transfer challenges. Turenne Groupe, one of France’s leading private equity firms, has been helping entrepreneurs with their innovation, development and transfer projects for more than 20 years.

H.A.C.Pharma is a pharmaceutical laboratory within the meaning of the French public health code. Since 2007, it has built up a portfolio of pharmaceutical products, which it makes available in France but also for certain molecules in Europe. As a recognized partner of the hospital sector, H.A.C.Pharma provides therapeutic solutions adapted to patients’ needs and health professionals’ expectations. H.A.C.Pharma strives to achieve this goal and to maintain the availability of vital and tested drugs on the market.

Jeantet (Turenne Santé’s legal counsel): Thierry Brun (partner), Maxime Brotz (Counsel), Maria Plakci and Pak-Hang Li (associates).

H.A.C.Pharma was advised by Dentons and Rothschild & Co.

Our last press releases

Jeantet strengthens its Corporate/M&A Department with the addiction of Quentin Mette as Counsel

Paris, 27 September 2022 – Quentin Mette, 36, joins Jeantet as Counsel to strengthen the corporate M&A department. éègraduated from the DJCE in Bordeaux with a double degree in business law and from Kedge Grande Ecole in corporate finance. Quentin started his professional career in 2011 as a lecturer at the University Montesquieu Bordeaux 4, […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises the China Medical System Group in connection with the acquisition of a participating interest in Eye Tech Care

Paris, 15 September 2022 – Jeantet has advised the Chinese group China Medical System in the context of (i) the acquisition of a participating interest, through certain subsidiaries of the group, of around 33.4% of the share capital of the French company Eye Tech Care and (ii) the signature of a license, collaboration and distribution […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises Pitch Immo on the acquisition of Groupe XF

Paris, August 2, 2022, Jeantet has advised Pitch Immo, a brand of the Altarea Group, on the acquisition of Groupe XF. Based in Toulouse, Groupe XF is a developer and planner specialising in new real estate in Occitania. As part of Pitch Immo’s growth plan in regional cities, this operation will enable it to offer […]

Paris | CORPORATE – M&A – PRIVATE EQUITY | REAL ESTATE | PUBLIC LAW – PUBLIC CONTRACTS

+

Jeantet advises the Emosia group on the acquisition of My Jolie Candle

Paris, July 28, 2022, Jeantet has advised the Emosia group, owner of Maison Berger Paris, on the acquisition of the My Jolie Candle start-up Emosia, the owner of Maison Berger Paris, Bougies la Française, and Ambiances Devineau, stands out as an emblematic brand and a leader in the market of home fragrances. My Jolie Candle, […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises ØRSTED on the acquisition of german wind turbine developer and operator OSTWIND

Paris, July 25, 2022, Jeantet has advised the Danish group Ørsted on the acquisition of the French business and portfolio of the German group Ostwind, developer, owner and operator of wind and photovoltaic farms, for an enterprise value of €689 million. With the acquisition of Ostwind, Ørsted enters the German and French markets and expands […]

Paris | CORPORATE – M&A – PRIVATE EQUITY | ENERGY | REAL ESTATE | FINANCING | BANK-FINANCE-REGULATORY

+

Jeantet advises Apollo on its €500 million investment in Air France-KLM

Paris, July 19, 2022, Jeantet advises Apollo Global Management on the signing of a final agreement for a €500 million investment in a subsidiary of Air France-KLM. Apollo Global Management and Air France-KLM announced that they have entered into a final agreement relating to the issuance of perpetual super-subordinated notes, fully subscribed by Apollo Global […]

Paris | CORPORATE – M&A – PRIVATE EQUITY | BANK-FINANCE-REGULATORY | TAX | RESTRUCTURING – LAW OF COMPANIES IN DIFFICULTY

+

Jeantet supports Sport Bridges Venture (SBV) in its entry into the capital of Paris FC

Paris, July 15, 2022, Jeantet supports Sport Bridges Venture (SBV), a consortium of French and American investors, in its acquisition of a minority stake in Paris FC. SBV becomes the fourth foreign investor in Paris FC, after the Kingdom of Bahrain in 2020, BRI Sports Holding in 2021 and Noah Football Group at the beginning […]

| CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises ABN AMRO Ventures in the context of the EUR 12.5M fundraising of DFNS.co

Paris,  July 6, 2022 – Jeantet has advised ABN AMRO Ventures in the context of the EUR 12.5M fundraising of DFNS.co.  DFNS.co, a French crypto-wallet start-up backed by Techstars and listed among the Future 40 start-up companies by the Station F, has raised EUR 12.5M to develop a secured crypto-custody protocol to secure digital assets. […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises german automotive and industry supplier Schaeffler in setting up a joint venture with Symbio, a Faurecia and Michelin Hydrogen Compagny

On 9 June 2022. Symbio, a Faurecia and Michelin hydrogen company, and Schaeffler Group, signed an agreement to establish Innoplate, a global 50:50 joint venture (JV) to produce fuel cell bipolar plates (BPP), a strategic fuel cell component. The JV and first plant are to be located in Haguenau (Alsace region), France, with the JV […]

Franco-German team, Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advised Silverfleet Capital on the sale of the CoreDux Group to Arcline Investment Management

Paris, on 8 June 2022 – Jeantet advised Silverfleet Capital on the sale of the CoreDux Group, a manufacturer of flexible gas and fluid artery systems with group companies in the Netherlands, France, Germany and the United States, to Arcline Investment Management. Silverfleet Capital was advised by a joint team of Jeantet and the Dutch […]

Paris | CORPORATE – M&A – PRIVATE EQUITY | REAL ESTATE | EMPLOYMENT

+

Jeantet advises Agrofert on the acquisition of Borealis’ nitrogen production business.

Paris, June 7, 2022 – Jeantet and the Austrian law firm Wolf Theiss have advised the Agrofert group, a European leader in the production of nitrogen fertilizers, on the acquisition of Borealis’ nitrogen production business, which includes fertilizers, melamine and technical nitrogen. The offer values Borealis’ “nitrogen” business on an enterprise value basis of EUR […]

Paris, Franco-German team | CORPORATE – M&A – PRIVATE EQUITY | EMPLOYMENT | BANK-FINANCE-REGULATORY | IP, TECH & DATA | REAL ESTATE | COMPETITION AND ECONOMIC LAW | PUBLIC LAW – PUBLIC CONTRACTS

+

Jeantet advises The Surgical Compagny Group (TSC GROUP) in connection with the sale of its distribution business in France and Benelux to Duomed Group

Paris, June 2, 2022 – Jeantet advised TSC Group, a leading manufacturer and distributor of specialized medical equipment and devices, in connection with the sale of its distribution business in France and Benelux to Duomed Group, a pan-European distributor of medical supplies. The TSC Group, which also includes the Medtech OEM business (via TSC PTM […]

Paris, Franco-German team | CORPORATE – M&A – PRIVATE EQUITY | TAX | EMPLOYMENT | BANK-FINANCE-REGULATORY | IP, TECH & DATA | REAL ESTATE | COMPETITION AND ECONOMIC LAW | PUBLIC LAW – PUBLIC CONTRACTS

+